Fast Lab Discovers an Effective Small-Molecule Allosteric Inhibitor of New Delhi Metallo-β-lactamase (NDM)
April 1, 2022 • by
Staff Writer
A new publication from the Walter Fast Lab features the discovery of an allosteric inhibitor of New Deli metallo-beta-lactamase for treating CRE through the use of high-throughput screening.
